Metastatic melanoma in a 95 years old patient responding to treatment with talimogene laherparepvec followed by nivolumab

被引：3
|
作者：
Naqash, Abdul R. [1 ]
Stroud, Geoffrey [1 ]
Collichio, Frances A. [2 ]
Muzaffar, Mahvish [1 ]
Sharma, Nitika [1 ]
Walker, Paul [1 ]
机构：
[1] East Carolina Univ, Div Hematol Oncol, 600 Moye Blvd, Greenville, NC 27858 USA
[2] Univ N Carolina, Div Hematol Oncol, Lineberger Comprehens Ctr, Chapel Hill, NC USA
来源：
ACTA ONCOLOGICA | 2017年 / 56卷 / 10期
关键词：
IPILIMUMAB; IMMUNOTHERAPY; COMBINATION;
D O I：
10.1080/0284186X.2017.1324212
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1327 / 1330
页数：4
相关论文
共 50 条
  • [1] Neoadjuvant Talimogene Laherparepvec for the Treatment of Metastatic Melanoma
    Stiles, Zachary E.
    Fleming, Martin D.
    Luce, Edward A.
    Deneve, Jeremiah L.
    AMERICAN SURGEON, 2017, 83 (07) : E266 - E268
  • [2] Talimogene laherparepvec in the treatment of melanoma
    Appleton, Elizabeth S.
    Turnbull, Samantha
    Ralph, Christy
    West, Emma
    Scott, Karen
    Harrington, Kevin
    Pandha, Hardev
    Melcher, Alan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (10) : 1517 - 1530
  • [3] Talimogene Laherparepvec: A Review in Unresectable Metastatic Melanoma
    Garnock-Jones, Karly P.
    BIODRUGS, 2016, 30 (05) : 461 - 468
  • [4] Talimogene Laherparepvec: A Review in Unresectable Metastatic Melanoma
    Karly P. Garnock-Jones
    BioDrugs, 2016, 30 : 461 - 468
  • [5] An evaluation of talimogene laherparepvec for the treatment of melanoma
    Broman, Kristy K.
    Zager, Jonathan S.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (01) : 9 - 14
  • [6] Talimogene Laherparepvec for the Treatment of Advanced Melanoma
    Ott, Patrick A.
    Hodi, F. Stephen
    CLINICAL CANCER RESEARCH, 2016, 22 (13) : 3127 - 3131
  • [7] Dermoscopic Guidance of Talimogene Laherparepvec Injection for Metastatic Melanoma
    Khalsa, Amrit
    Bacik, Lindsay
    Pameijer, Colette
    Seiverling, Elizabeth
    DERMATOLOGIC SURGERY, 2018, 44 (07) : 1026 - 1028
  • [8] NICE guidance for talimogene laherparepvec for unresectable metastatic melanoma
    Adam, Jane
    Robertson, Janet
    Donegan, Eleanor
    Voicechovskaja, Irina
    LANCET ONCOLOGY, 2016, 17 (11): : 1485 - 1486
  • [9] Talimogene laherparepvec pseudolymphomatous reaction mimicking metastatic melanoma
    Henning, Ania
    Agnese, Doreen
    Chung, Catherine G.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2021, 48 (11) : 1423 - 1426
  • [10] The safety of talimogene laherparepvec for the treatment of advanced melanoma
    Gangi, Alexandra
    Zager, Jonathan S.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (02) : 265 - 269
12345